Regulatory T Cells in GVHD Therapy

Wenwen Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Erlie Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Frontiers in Immunology
June 18, 2021
10.3389/fimmu.2021.697854
Cited by 61

Related Papers

Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation
|Cellular and Molecular Immunology|2019|36
Effect of Antithymocyte Globulin Source on Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia
|Transplantation and Cellular Therapy|2017|23
Comparison of outcomes of haploidentical donor hematopoietic stem cell transplantation supported by third-party cord blood with HLA-matched unrelated donor transplantation
|Leukemia & lymphoma/Leukemia and lymphoma|2019|14
B Lymphocyte Chemoattractant (CXCL13) Is an Indicator of Acute Gastrointestinal GVHD in Murine Model
|Inflammation|2017|5
Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
|Blood|2022|0